# Evaluation of 627 in Healthy Adult Subjects

> **NCT07065136** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.** · enrollment: 108 (estimated)

## Conditions studied

- Healthy Subjects (HS)

## Interventions

- **BIOLOGICAL:** 627
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07065136
- **Lead sponsor:** Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-20
- **Primary completion:** 2026-09-18
- **Final completion:** 2026-09-18
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07065136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07065136, "Evaluation of 627 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07065136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*